KORU Medical Systems, Inc. (KRMD)

KORU Medical Systems Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	29.32	28.52	27.9	23.49	24.18	23.16
Revenue Growth (YoY)	0.96%	2.23%	18.76%	-2.84%	4.38%	33.47%
Cost of Revenue	11.66	11.81	12.53	9.72	9.24	8.31
Gross Profit	17.66	16.71	15.37	13.77	14.94	14.85
Selling, General & Admin	20.3	20.37	20.61	17.86	12.03	9.77
Research & Development	5.65	5.74	4.96	2.47	1.3	0.74
Other Operating Expenses	0.89	0.87	0.59	0.46	2.87	3.76
Operating Expenses	26.84	26.98	26.15	20.8	16.19	14.27
Operating Income	-9.17	-10.27	-10.78	-7.03	-1.25	0.59
Other Expense / Income	-0.45	-0.5	-0.11	-0.67	-0.06	-0.11
Pretax Income	-8.72	-9.77	-10.68	-6.36	-1.19	0.7
Income Tax	4.54	3.97	-2.01	-1.8	0.02	0.13
Net Income	-13.27	-13.74	-8.66	-4.56	-1.21	0.56
Net Income Growth	-	-	-	-	-	-38.02%
Shares Outstanding (Basic)	46	46	45	44	42	39
Shares Outstanding (Diluted)	46	46	45	44	42	39
Shares Change	0.49%	1.33%	1.39%	5.86%	7.34%	0.36%
EPS (Basic)	-0.28	-0.30	-0.19	-0.10	-0.03	0.01
EPS (Diluted)	-0.28	-0.30	-0.19	-0.10	-0.03	0.01
EPS Growth	-	-	-	-	-	-50.00%
Free Cash Flow	-1.22	-5.68	-8.17	-4.66	-1.64	0.34
Free Cash Flow Per Share	-0.03	-0.12	-0.18	-0.10	-0.04	0.01
Gross Margin	60.24%	58.59%	55.09%	58.62%	61.78%	64.13%
Operating Margin	-31.29%	-36.01%	-38.65%	-29.93%	-5.19%	2.53%
Profit Margin	-45.24%	-48.18%	-31.05%	-19.42%	-5.01%	2.44%
Free Cash Flow Margin	-4.17%	-19.90%	-29.27%	-19.82%	-6.78%	1.46%
Effective Tax Rate	-	-	-	-	-	18.96%
EBITDA	-7.83	-8.9	-10.09	-5.9	-0.78	1.04
EBITDA Margin	-26.71%	-31.22%	-36.16%	-25.12%	-3.21%	4.48%
Depreciation & Amortization	0.89	0.87	0.59	0.46	0.42	0.34
EBIT	-8.72	-9.77	-10.68	-6.36	-1.19	0.7
EBIT Margin	-29.74%	-34.27%	-38.27%	-27.09%	-4.94%	3.01%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).